A Randomized, Double-blind, Placebo-controlled, Ascending Single Oral Dose, Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects

Trial Profile

A Randomized, Double-blind, Placebo-controlled, Ascending Single Oral Dose, Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jul 2017

At a glance

  • Drugs KD 101 (Primary)
  • Indications Obesity
  • Focus Pharmacokinetics
  • Sponsors Kwang Dong Pharmaceutical
  • Most Recent Events

    • 11 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Mar 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Apr 2014 to 1 Aug 2014.
    • 11 Mar 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top